Evidence map›Paper›PMID 29910794›Full record

ReviewFrontiers in microbiology2018

Extremophilic Microfactories: Applications in Metal and Radionuclide Bioremediation.

Catarina R Marques

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. The outer membrane inApplied and environmental microbiology · 2025
    Article
  3. Review
  4. Extremophiles in a changing world.Extremophiles : life under extreme conditions · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Bacterial diversity in aqueous/sludge phases within diesel fuel storage tanks.World journal of microbiology & biotechnology · 2020
    Article
  10. Review
  11. Review
  12. Discovery and Characterization of NativeApplied and environmental microbiology · 2019
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Catarina R MarquesDepartamento de Biologia and Centro de Estudos do Ambiente e do Mar, Universidade de Aveiro, Aveiro, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metals and radionuclides (M&Rs) are a worldwide concern claiming for resilient, efficient, and sustainable clean-up measures aligned with environmental protection goals and global change constraints. The unique defense mechanisms of extremophilic bacteria and archaea have been proving usefulness towards M&Rs bioremediation. Hence, extremophiles can be viewed as microfactories capable of providing specific and controlled services (i.e., genetic/metabolic mechanisms) and/or products (e.g., biomolecules) for that purpose. However, the natural physiological plasticity of such extremophilic microfactories can be further explored to nourish different hallmarks of M&R bioremediation, which are scantly approached in the literature and were never integrated. Therefore, this review not only briefly describes major valuable extremophilic pathways for M&R bioremediation, as it highlights the advances, challenges and gaps from the interplay of 'omics' and biological engineering to improve extremophilic microfactories performance for M&R clean-up. Microfactories' potentialities are also envisaged to close the M&R bioremediation processes and shift the classical idea of never 'getting rid' of M&Rs into making them 'the belle of the ball' through bio-recycling and bio-recovering techniques.

Indexed as

extremophilic bacteria and archaeagenetic engineeringmetal-radionuclide recycling/recoveringmeta-‘omics’mine wastessynthetic biology

Identifiers

PMID29910794
PMCPMC5992296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.